期刊文献+

结直肠癌患者血清转化生长因子β1含量检测及临床意义 被引量:3

Determination and Clinical Significance of Serum Level of Transforming Growth Factor-Beta 1 in Patients with Colorectal Cancer
原文传递
导出
摘要 目的:探讨结直肠癌患者血清转化生长因子(TGF)-β1含量变化的临床意义。方法:采用ELISA法检测185例结直肠癌,46例结直肠腺瘤息肉、33例炎症性肠病患者和30位正常对照者及结直肠癌术后随访组、复发组血清TGFβ-1与CEA的含量,分析血清TGFβ-1含量与结直肠癌病理特征的关系。结果:结直肠癌组及肿瘤复发组TGFβ-1和CEA含量显著高于正常组(P<0.001);结直肠腺瘤息肉组及炎症性肠病组TGFβ-1含量亦明显高于正常组(P<0.05)而CEA含量无明显升高。术后各随访组TGFβ-1与CEA含量较术前显著降低(P<0.001)。结直肠癌组血清TGFβ-1含量与肿瘤分化程度、病理分期均呈显著正相关(P<0.01),与肿瘤大小相关(P<0.05)而与肿瘤部位无关。结论:血清TGF-β1可作为结直肠癌的具有一定临床价值的肿瘤标志物,有助于其临床诊断与评价、术后复发及高危对象的监测。 Objective: To study the change of serum transforming growth factor-beta1(TGF-β1) level in patients with colorectal cancer and its clinical significance.Methods: The serum levels of TGF-β1 and carcinoembryonic antigen(CEA) were measured by ELISA technique in 185 cases of colorectal cancer,46 colorectal adenoma,33 inflammatory bowel disease,and 30 normal controls.The relation between serum TGF-β1 level and clinical and pathologic features of colorectal cancer was evaluated.Results: The serum levels of TGF-β1 and CEA in colorectal cancer group and recurred colorectal cancer group were significantly higher than those in normal control group respectively(all P〈0.001).The serum TGF-β1 level in colorectal adenoma group and inflammatory bowel disease group were also markedly higher than that in normal group(both P〈0.05).The serum TGF-β1 levels in colorectal cancer group were positively correlated with pathologic features and not with the location of colorectal cancer.Conclusion: Serum TG...更多F-β1 level may be a valuable marker for colorectal cancer in the diagnosis and the monitoring of recurrence after resection in high risk population.
出处 《武汉大学学报(医学版)》 CAS 北大核心 2009年第5期640-643,共4页 Medical Journal of Wuhan University
关键词 TGFΒ-1 CEA 血清 结直肠癌 Transforming Growth Factor-Beta1 Carcinoembryonic Antigen Serum Colorectal Cancer
  • 相关文献

参考文献8

  • 1Coban S, Yuksel O, Kockar MC, et al. The significance of serum transforming growth factor beta 1 in detecting of gastric and colon cancers[J]. Hepatogastroenterology,2007,54(77) :1 472 1 476. 被引量:1
  • 2Wang KS, Hu ZL, Li JH, et al. Enhancement of metastatic and invasive capacity of gastric cancer cells by transforming growth factor-betal [J]. Acta Biochim Biophys Sin, 2006,38(3) :179-186. 被引量:1
  • 3Lin Y, Kikuchi S, Obata Y, et al. Serum levels of transforming growth faclor betal are significantlceorrelated with venous invasion in patients with gastric cancer[J]. J Gastroenterol Hepatol, 2006,21 (2) : 432- 437. 被引量:1
  • 4Saltzman BS, Yamamoto JF, Decker R, et al. Association of genetic variation in the transforming growth factor beta-1 gene with serum levels and risk of colorectal neoplasia[J]. Cancer Res,2008,68(4) :1 236-1 244. 被引量:1
  • 5Yatsuya H, Toyoshima H, Tamakoshi K, et al. Serum levels of insulin-like growth factor Ⅰ,Ⅱ, and binding protein 3, transforming growth factor beta 1, soluble fas ligand and superoxide dismutase activity in stomach cancer cases and their controls in the JACC study[J]. J Epidemiol, 2005,15 (Suppl 2 ) : S120-S125. 被引量:1
  • 6郑树,万德森.结直肠癌[M].北京:北京大学医学出版社,2008,33-35. 被引量:7
  • 7Kim HP, Lee MS, Yu J, et ai. TGF-betal(transforming growth factor-beta1)-mediated adhesion of gastric carcinoma cells involves a decrease in Ras/ERKs (extracellular-signal-regulated kinases) cascade activity dependent on c-Src activity[J]. Biochem J, 2004,379 (Pt 1) : 141-150. 被引量:1
  • 8Huang A, Gilmour JW, Imami N, et al. Increased serum transforming growth faetor-betal in human colorectal cancer correlates with reduced circulating dendritic cells and increased colonic Langerhans cell infiltration [J]. Clin Exp Immunol,2003,134(2):270-278. 被引量:1

共引文献6

同被引文献36

  • 1胡兵,沈克平.黄芪抗肿瘤作用及机制研究[J].中药材,2008,31(3):461-465. 被引量:62
  • 2陈智伟,廖美琳.RECIST标准在肿瘤治疗疗效评价中的应用[J].中国肿瘤,2004,13(10):616-618. 被引量:179
  • 3王旭东,战忠利.TGF-β及其受体与肿瘤的研究进展[J].中国肿瘤临床,2005,32(17):1016-1020. 被引量:28
  • 4Li MO,Flavell RA. TGF-β:a master of all T cell trades[J].Cell,2008,(03):392-404. 被引量:1
  • 5Kang JS,Liu C,Derynck R. New regulatory mechanisms of TGF-beta receptor function[J].Trends in Cell Biology,2009,(08):385-394. 被引量:1
  • 6Gordon KJ,Blobe GC. Role of transforming growth factor-beta superfamily signaling pathways in human disease[J].Biochimica Et Biophysica Acta,2008,(04):197-228. 被引量:1
  • 7Li MO,Wan YY,Sanjabi S. Transforming growth factor-beta regulation of immune responses[J].Annual Review of Immunology,2006,(24):99-146. 被引量:1
  • 8Liu Z,Kohayashi K,Dinther M. VEGF and inhibitors of TGF-beta type-1 receptor kinase synergistically promote blood-vessel formation by inducing alpha5-integrin expression[J].Journal of Cell Science,2009,(18):3294-3302. 被引量:1
  • 9Prud′homme GJ. Pathobiology of transforming growth factor beta in cancerfibrosis and immunologic disease and therapeutic considerations[J].Laboratory Investigation,2007,(11):1077-1091.doi:10.1038/labinvest.3700669. 被引量:1
  • 10Kumar S,Guleria R,Mohan A. Efficacy of plasma TGF-β1 level in predicting therapeutic efficacy and prognosis in patients with advanced non-small cell lung cancer[J].Cancer Investigation,2011,(03):202-207. 被引量:1

引证文献3

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部